By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fiscal second-quarter revenues for Myriad Genetics rose 8 percent, driven by sales of its BRACAnalysis product, the company reported after the close of the market on Thursday.

For the three months ended Dec. 31, 2010, revenues for the molecular diagnostics firm rose to $100.4 million, compared to $92.8 million a year ago, surpassing consensus Wall Street estimates of $98.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.